Tuesday, June 23, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 637 of 1,261

  1. US 9629930

    Methods and compositions for treating hemophilia B

    Sangamo Biosciences, Inc. · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted

  2. US 9629911

    Photoreactive regulator of protein function and methods of use thereof

    The Regents of the University of California · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted

  3. US 9629899

    Targeted cargo protein combination therapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted

  4. US 9629897

    Methods of producing and using regulatory B-cells

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted

  5. US 9629903

    Factor IX polypeptides and methods of use thereof

    BIOVERATIV THERAPEUTICS INC. · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted

  6. US 9629860

    Acyclic nucleoside phosphonate diesters

    The Regents of the University of California · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted

  7. US 9629848

    Compounds that modulate autoimmunity and methods of using the same

    The Regents of the University of Colorado, a Body Corporate · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted

  8. US 9629385

    Dietary composition containing cistanche deserticola polysaccharide with inhibitory effects on colon cancer

    INFINITUS (CHINA) COMPANY LTD. · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted

  9. US 9629816

    Small molecule therapeutic compounds targeting thioesterase deficiency disorders and methods of using the same

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted

  10. US 9629799

    Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

    Rani Therapeutics, LLC · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted

  11. US 9623020

    Thio compounds

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted

  12. US 9624509

    Modulation of stem cells using zinc finger proteins

    Sangamo Biosciences, Inc. · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted

  13. US 9625473

    Cytokine biomarkers as predictive biomarkers of clinical response for glatiramer acetate

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted

  14. US 9622983

    Sustained-release formulations of topiramate

    Supernus Pharmaceuticals, Inc. · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted

  15. US 9624472

    Production of insulin producing cells

    Regents of the University of Minnesota · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted

  16. US 9624475

    Genetically stable live attenuated respiratory syncytial virus vaccine and its production

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted

  17. US 9622974

    Formation of stable submicron peptide or protein particles by thin film freezing

    The Board of Regents of the University of Texas · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted

  18. US 9624496

    Modulation of apolipoprotein C-III expression

    Ionis Pharmaceuticals, Inc. · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted

  19. US 9624484

    Engineered primate L-methioninase for therapeutic purposes

    The Board of Regents of the University of Texas System · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted

  20. US 9624283

    Peptide compounds and methods of production and use thereof

    The Board of Regents of the University of Oklahoma · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted

  21. US 9624274

    Mutated structural protein of a parvovirus

    Ludwig-Maximilians-Universitat Munchen · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted

  22. US 9624303

    Single-chain variable fragment anti-CD133 antibodies and uses thereof

    Regents of the University of Minnesota · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted

  23. US 9624259

    Compositions and methods for scaffold formation

    REGENTIS BIOMATERIALS LTD. · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted

  24. US 9624255

    Carbohydrate-mediated tumor targeting

    THE ARIZONA BOARD OF REGENTS · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.